Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
India seeks global bids for 65 key medicines due to domestic supply shortages, with exemptions expanded until 2027.
India is evaluating global tenders for over 65 patented medicines, including treatments for cancer, diabetes, heart disease, and obesity, due to insufficient domestic production.
The move, driven by urgent healthcare needs and supply gaps, aims to improve access for central agencies like the armed forces’ medical services and the Employees’ State Insurance Corporation.
Exemptions from local procurement rules—typically limiting global tenders to purchases over ₹200 crore—are being expanded, with 128 drugs already exempt until March 2027.
The Department of Pharmaceuticals has invited objections from Indian manufacturers by December 5 to assess domestic production feasibility.
Final decisions await inter-ministerial approval, with a formal notification expected soon.
India busca licitaciones globales para 65 medicamentos clave debido a la escasez de suministro doméstico, con exenciones ampliadas hasta 2027.